Taxanes for breast cancer during pregnancy: a systematic review

O Mir, P Berveiller, F Goffinet, JM Treluyer… - Annals of …, 2010 - annalsofoncology.org
The co-occurrence of breast cancer and pregnancy is an important issue for the forthcoming
years, given the trend for women to postpone childbearing [1]. Although the use of …

Drug disposition in cystic fibrosis

E Rey, JM Tréluyer, G Pons - Clinical pharmacokinetics, 1998 - Springer
… Prandota J. Drug disposition in cystic fibrosis: progress in understanding pathophysiology
and … Prandota J. Clinical pharmacology of antibiotics and other drugs in cystic fibrosis. Drugs …

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

…, N Roche, TA Szwebel, SH Merkling, JM Treluyer… - Science, 2020 - science.org
Coronavirus disease 2019 (COVID-19) is characterized by distinct patterns of disease
progression that suggest diverse host immune responses. We performed an integrated immune …

Emerging therapeutic options for breast cancer chemotherapy during pregnancy

…, F Goffinet, G Pons, JM Treluyer… - Oncology in Clinical …, 2008 - journals.viamedica.pl
Breast cancer is the commonest solid tumor observed during pregnancy. Anthracycline-based
chemotherapy is feasible during the 2nd and 3rd trimesters of pregnancy, but few data are …

[HTML][HTML] Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea

…, D Pannetier, AM Taburet, JM Treluyer, J Kolie… - PLoS …, 2016 - journals.plos.org
Background Ebola virus disease (EVD) is a highly lethal condition for which no specific
treatment has proven efficacy. In September 2014, while the Ebola outbreak was at its peak, the …

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic …

…, A Mogenet, J Banchereau, JM Treluyer… - Annals of the …, 2011 - ard.bmj.com
Objectives To assess the efficacy of the interleukin 1 receptor antagonist anakinra in systemic-onset
juvenile idiopathic arthritis (SJIA). Methods A multicentre, randomised, double-blind, …

Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome

…, A Lim, JM Treluyer, S Héritier, F Lefrère, J Magalon… - Jama, 2015 - jamanetwork.com
Importance Wiskott-Aldrich syndrome is a rare primary immunodeficiency associated with
severe microthrombocytopenia. Partially HLA antigen–matched allogeneic hematopoietic stem …

The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients

…, C Roux, M Rudwaleit, A Saraux, JM Treluyer… - Joint bone spine, 2011 - Elsevier
OBJECTIVES: The French Society of Rheumatology has initiated a large national multicenter,
longitudinal, prospective follow-up of patients presenting with early inflammatory back pain …

Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation

T Cresteil, B Monsarrat, P Alvinerie, JM Tréluyer… - Cancer research, 1994 - AACR
The biotransformation of taxol by human liver was investigated in vitro with microsomes
isolated from adult and developing human tissues. In vitro, no metabolism was detected with …

Off label and unlicensed drug use among French office based paediatricians

M Chalumeau, JM Treluyer, B Salanave… - Archives of disease in …, 2000 - adc.bmj.com
AIMS To determine the extent of off label and unlicensed drug use in French office based
paediatric practice. METHODS A prospective one day survey of all written prescriptions, for …